PT  - JOURNAL ARTICLE
AU  - Sinclair, Heather Q.
ED  - Held, Claes
TI  - Ticagrelor May Be an Effective Alternative to Clopidogrel in Patients with ACS Who Subsequently Undergo CABG
DP  - 2010 May 01
TA  - MD Conference Express
PG  - 19--20
VI  - 10
IP  - 2
4099  - http://mdc.sagepub.com/content/10/2/19.short
4100  - http://mdc.sagepub.com/content/10/2/19.full
AB  - In patients with acute coronary syndrome (ACS) who are undergoing coronary artery bypass grafting (CABG), treatment with ticagrelor within 7 days prior to surgery is associated with lower rates of mortality after CABG and comparable rates of CABG-related bleeding compared with clopidogrel. Findings from a retrospective analysis of the nonrandomized subgroup of patients who required CABG (n=1261) within 7 days of last intake of study drug from the Platelet Inhibition and Patient Outcomes [PLATO; NCT00391872] study, comparing ticagrelor and clopidogrel.